ECSP066670A - Prodroga florfenicol con mejor solubilidad en agua - Google Patents
Prodroga florfenicol con mejor solubilidad en aguaInfo
- Publication number
- ECSP066670A ECSP066670A EC2006006670A ECSP066670A ECSP066670A EC SP066670 A ECSP066670 A EC SP066670A EC 2006006670 A EC2006006670 A EC 2006006670A EC SP066670 A ECSP066670 A EC SP066670A EC SP066670 A ECSP066670 A EC SP066670A
- Authority
- EC
- Ecuador
- Prior art keywords
- florfenicol
- water
- products
- better solubility
- solubility
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/094—Esters of phosphoric acids with arylalkanols
Abstract
La presente invención revela los ésteres de florfenicol (prodrogas) y los análogos de florfenicol que tienen una solubilidad superior en agua que son hidrolizados hasta el florfenicol o el análogo respectivo de florfenicol in vivo, después de la administración a un animal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53222703P | 2003-12-23 | 2003-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP066670A true ECSP066670A (es) | 2006-10-25 |
Family
ID=34738768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2006006670A ECSP066670A (es) | 2003-12-23 | 2006-06-22 | Prodroga florfenicol con mejor solubilidad en agua |
Country Status (18)
Country | Link |
---|---|
US (2) | US7153842B2 (es) |
EP (1) | EP1696934B1 (es) |
JP (2) | JP4719160B2 (es) |
KR (1) | KR20060111605A (es) |
CN (1) | CN100579532C (es) |
AR (1) | AR046970A1 (es) |
BR (1) | BRPI0418133A2 (es) |
CA (1) | CA2550660C (es) |
EC (1) | ECSP066670A (es) |
IL (2) | IL176342A (es) |
MX (1) | MXPA06007215A (es) |
NO (1) | NO20063244L (es) |
NZ (1) | NZ547592A (es) |
PE (1) | PE20050822A1 (es) |
RU (1) | RU2006126519A (es) |
TW (1) | TWI262181B (es) |
WO (1) | WO2005063257A1 (es) |
ZA (1) | ZA200605165B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200505425A (en) * | 2003-05-29 | 2005-02-16 | Schering Plough Ltd | Compositions and method for treating infection in cattle and swine |
US7439268B2 (en) | 2003-07-18 | 2008-10-21 | Idexx Laboratories | Compositions containing prodrugs of florfenicol and methods of use |
CN100579532C (zh) * | 2003-12-23 | 2010-01-13 | 先灵-普劳有限公司 | 具有改善水溶性的氟苯尼考前药 |
US7361689B2 (en) * | 2003-12-31 | 2008-04-22 | Schering-Plough Animal Health Corporation | Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof |
EP1799636B1 (en) | 2004-09-23 | 2008-08-27 | Schering-Plough Ltd. | Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
US7705038B2 (en) | 2004-11-19 | 2010-04-27 | Intervet, Inc. | Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivatives |
CA2609574A1 (en) * | 2005-06-09 | 2006-12-21 | Schering-Plough Ltd. | Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives |
US8119667B2 (en) * | 2005-12-29 | 2012-02-21 | Schering-Plough Animal Health Corporation | Carbonates of fenicol antibiotics |
MX2009006468A (es) * | 2006-12-13 | 2009-08-20 | Schering Plough Ltd | Profarmacos de fenicol solubles en agua en un sistema de vehiculo lipofilico. |
MX2009006467A (es) * | 2006-12-13 | 2009-08-21 | Schering Plough Ltd | Profarmacos solubles en agua de cloranfenicol, tiamfenicol y analogos de los mismos. |
WO2008076259A1 (en) * | 2006-12-13 | 2008-06-26 | Schering-Plough Ltd. | Water-soluble prodrugs of florfenicol and its analogs |
TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
MX368680B (es) | 2007-06-27 | 2019-10-11 | Du Pont | Administración subcutánea de un derivado de isoxazol-benzamida para usarse en un método para proteger un mamífero de una pulga. |
US20090170954A1 (en) * | 2007-12-14 | 2009-07-02 | Schering-Plough Ltd. | Process for Recovering Florfenicol and Florfenicol Analogs |
WO2010014566A2 (en) * | 2008-07-30 | 2010-02-04 | Intervet International B.V. | Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol |
UA110924C2 (uk) | 2009-08-05 | 2016-03-10 | Е. І. Дю Пон Де Немур Енд Компані | Мезоіонні пестициди |
MX2012001646A (es) | 2009-08-05 | 2012-03-21 | Du Pont | Pesticidas mesoionicos. |
JP2013501059A (ja) | 2009-08-05 | 2013-01-10 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | メソイオン性殺虫剤 |
WO2012087630A1 (en) | 2010-12-20 | 2012-06-28 | E.I. Du Pont De Nemours And Company | Pyridine and pyrimidine compounds for controlling invertebrate |
CA2834999A1 (en) | 2011-05-02 | 2012-11-08 | Zoetis Llc | Novel cephalosporins useful as antibacterial agents |
AU2012273133A1 (en) | 2011-06-20 | 2013-11-07 | E. I. Du Pont De Nemours And Company | Heterocyclic compounds for treating helminth infections |
AU2012346433A1 (en) | 2011-11-28 | 2014-05-08 | E. I. Du Pont De Nemours And Company | N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics |
WO2013158422A1 (en) | 2012-04-17 | 2013-10-24 | E. I. Du Pont De Nemours And Company | Heterocyclic compounds for controlling invertebrate pests |
WO2014099837A1 (en) | 2012-12-18 | 2014-06-26 | E. I. Du Pont De Nemours And Company | Sulfonamide anthelmintics |
CN103242363B (zh) * | 2013-04-18 | 2015-10-28 | 湖北龙翔药业有限公司 | 氟苯尼考磷酸二酯及盐及其制备方法 |
CN103923118A (zh) * | 2014-04-08 | 2014-07-16 | 张家港威胜生物医药有限公司 | 一种水溶性氟苯尼考衍生物的合成方法 |
CN105111234B (zh) * | 2015-09-23 | 2017-05-17 | 河北远征禾木药业有限公司 | 一种氟苯尼考磷酸酯的合成方法 |
CN110078729A (zh) * | 2019-06-11 | 2019-08-02 | 石家庄学院 | 一种水溶性氟苯尼考前药及其制备方法 |
CN115286544A (zh) * | 2022-10-08 | 2022-11-04 | 世华合创生物技术开发(山东)有限公司 | 一种氟苯尼考衍生物、制备方法及其在抗细菌感染的应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2776992A (en) | 1956-03-14 | 1957-01-08 | Du Pont | Trifluoromethylsulfonylphenyldichloracetamidopropandiol |
US4235892A (en) * | 1979-02-05 | 1980-11-25 | Schering Corporation, Patent Dept. | 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor |
FR2562543B1 (fr) * | 1984-04-10 | 1987-09-25 | Elf Aquitaine | Nouveaux phosphonites cycliques, leur preparation et applications |
US5352832A (en) | 1992-12-18 | 1994-10-04 | Schering Corporation | Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates |
US6864240B1 (en) | 1999-06-15 | 2005-03-08 | Elan Pharmaceuticals, Inc. | Dipeptide inhibitors of β-secretase |
US6670344B2 (en) | 2000-09-14 | 2003-12-30 | Bristol-Myers Squibb Company | Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts |
CA2418102A1 (en) | 2001-06-15 | 2002-12-27 | George R. Pettit | Combretastatin a-3 prodrug |
BR0308289A (pt) | 2002-03-08 | 2005-01-11 | Schering Plough Ltd | Antibióticos do tipo florfenicol |
US7439268B2 (en) * | 2003-07-18 | 2008-10-21 | Idexx Laboratories | Compositions containing prodrugs of florfenicol and methods of use |
CN100579532C (zh) * | 2003-12-23 | 2010-01-13 | 先灵-普劳有限公司 | 具有改善水溶性的氟苯尼考前药 |
US7361689B2 (en) | 2003-12-31 | 2008-04-22 | Schering-Plough Animal Health Corporation | Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof |
-
2004
- 2004-12-20 CN CN200480038867A patent/CN100579532C/zh active Active
- 2004-12-20 TW TW093139689A patent/TWI262181B/zh not_active IP Right Cessation
- 2004-12-20 AR ARP040104805A patent/AR046970A1/es not_active Application Discontinuation
- 2004-12-20 US US11/016,794 patent/US7153842B2/en active Active
- 2004-12-20 BR BRPI0418133-6A patent/BRPI0418133A2/pt not_active IP Right Cessation
- 2004-12-20 WO PCT/US2004/042591 patent/WO2005063257A1/en active Application Filing
- 2004-12-20 KR KR1020067012460A patent/KR20060111605A/ko not_active Application Discontinuation
- 2004-12-20 MX MXPA06007215A patent/MXPA06007215A/es active IP Right Grant
- 2004-12-20 EP EP04814736.7A patent/EP1696934B1/en active Active
- 2004-12-20 NZ NZ547592A patent/NZ547592A/xx not_active IP Right Cessation
- 2004-12-20 CA CA2550660A patent/CA2550660C/en not_active Expired - Fee Related
- 2004-12-20 JP JP2006547183A patent/JP4719160B2/ja not_active Expired - Fee Related
- 2004-12-20 RU RU2006126519/04A patent/RU2006126519A/ru not_active Application Discontinuation
-
2005
- 2005-01-03 PE PE2005000020A patent/PE20050822A1/es not_active Application Discontinuation
-
2006
- 2006-06-15 IL IL176342A patent/IL176342A/en not_active IP Right Cessation
- 2006-06-22 ZA ZA200605165A patent/ZA200605165B/xx unknown
- 2006-06-22 EC EC2006006670A patent/ECSP066670A/es unknown
- 2006-07-12 NO NO20063244A patent/NO20063244L/no not_active Application Discontinuation
- 2006-08-29 US US11/511,810 patent/US7572777B2/en active Active
-
2009
- 2009-07-23 IL IL200041A patent/IL200041A0/en unknown
-
2011
- 2011-02-23 JP JP2011037689A patent/JP2011148804A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2005063257A1 (en) | 2005-07-14 |
NO20063244L (no) | 2006-09-20 |
MXPA06007215A (es) | 2006-08-18 |
EP1696934B1 (en) | 2013-05-29 |
TWI262181B (en) | 2006-09-21 |
IL176342A (en) | 2011-08-31 |
PE20050822A1 (es) | 2005-10-01 |
RU2006126519A (ru) | 2008-01-27 |
JP4719160B2 (ja) | 2011-07-06 |
US7572777B2 (en) | 2009-08-11 |
CN1897954A (zh) | 2007-01-17 |
ZA200605165B (en) | 2007-12-27 |
IL200041A0 (en) | 2010-04-15 |
AU2004308913A1 (en) | 2005-07-14 |
JP2011148804A (ja) | 2011-08-04 |
AR046970A1 (es) | 2006-01-04 |
CA2550660C (en) | 2011-03-15 |
US20070021387A1 (en) | 2007-01-25 |
KR20060111605A (ko) | 2006-10-27 |
NZ547592A (en) | 2009-07-31 |
CN100579532C (zh) | 2010-01-13 |
IL176342A0 (en) | 2006-10-05 |
JP2007516286A (ja) | 2007-06-21 |
TW200533640A (en) | 2005-10-16 |
EP1696934A1 (en) | 2006-09-06 |
BRPI0418133A2 (pt) | 2009-03-24 |
CA2550660A1 (en) | 2005-07-14 |
US7153842B2 (en) | 2006-12-26 |
US20050182031A1 (en) | 2005-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP066670A (es) | Prodroga florfenicol con mejor solubilidad en agua | |
CY1122681T1 (el) | Απο του στοματος σκευασματα αναλογων κυτιδινης και μεθοδοι χρησης αυτων | |
PA8553001A1 (es) | Compuestos biciclicos aromaticos sustituidos con amino-alquilo, procedimiento para su preparacion y su utilizacion como medicamentos. | |
NI200300042A (es) | Compuestos que modulan la actividad de ppar y metodos para su preparacion. | |
DOP2011000264A (es) | Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia | |
ATE349207T1 (de) | Verstärkte wirkung mehrfach ungesättigter fettsäuren | |
CR20110568A (es) | Guía con sensor | |
AR068185A1 (es) | Composiciones de tabletas de desintegracion oral de lamotrigina | |
CO6290631A2 (es) | Composición oral que contiene amino ácidos y un agente blanqueador | |
CY1121474T1 (el) | Συνδυασμος αντιϊικων παραγοντων αμεσης δρασης και ριμπαβιρινης για την θεραπευτικη αγωγη ασθενων me hcv | |
HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
CY1108700T1 (el) | Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης | |
BRPI0620229A8 (pt) | formulação | |
EA200501819A1 (ru) | Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке | |
AR050908A1 (es) | Uso de benzopiranonas trisustituidas | |
CL2008003006A1 (es) | Uso de ester metilico del acido (-)-(3ar,4s,7ar)-4-hidroxi-4-m-toliletinil-octahidro-indol-1-carboxilico en base libre o en forma de sal para el tratamiento, prevencion o retraso de la progresion de la disquinesia de parkinson asociada a l-dopa; uso de la composicion farmaceutica; uso de una composicion que ademas comprende l-dopa. | |
AR035284A1 (es) | Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion | |
MA50047A (fr) | Administration orale d'analogues peptidiques de glp-1 | |
ATE347358T1 (de) | Schwimmende orale formulierungen mit kontrollierter freisetzung von betain | |
UY25356A1 (es) | Polisacaridos de sintesis,procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
RU2009128593A (ru) | Средства борьбы с паразитами животных | |
MX2009005228A (es) | Composiciones incrustadas en matriz que tienen acidos organicos y acidos grasos. | |
HN2003000040A (es) | Acidos 3-(imidazolil)-2-aminopropanoicos | |
PA8553201A1 (es) | Formulaciones en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otras sustancias activas, y su utilizacion | |
NI201200196A (es) | Agentes terapéuticos 976 |